My Home Plus vs Philips Everflo 5 Liter Oxygen Concentrator

Editor’s note — Everflo discontinued. Philips has discontinued the Everflo worldwide; it is no longer in production and remaining units are end-of-line stock. For an in-production 5 LPM alternative available in India, consider the Home Medix HM-KV (up to 5 L/min, 93% ±3%, ≤40 dB, 3-year warranty). The comparison below is retained for reference.

The certified reference vs a thin-catalogue import

The Philips Respironics Everflo 5 LPM is the reference FDA-approved 5 LPM stationary in the Indian market, priced at ₹43,699 (since discontinued) (indicative retail, 2026) and backed by Philips Respironics India’s dealer-and-service network. My Home Plus is a budget 5 LPM concentrator sold through Indian e-commerce and hospital-supply channels, positioned in the sub-₹35,000 band as a low-price alternative to imported or premium-domestic units. The two machines are not in the same tier — the Everflo sits in the FDA-approved imported class, My Home Plus sits in the unbranded-import budget class — and the buying decision comes down to whether the cost saving on My Home Plus offsets the lost certification, safety features, and service depth.

Note on product data: My Home Plus does not have a detailed product JSON in HHZ’s content collection at the time of writing. This comparison uses the documented spec sheet for the Philips Everflo paired with general public brand information for My Home Plus — the My Home Plus side reflects typical positioning for budget import 5 LPMs in the Indian market rather than a tested spec sheet. Buyers should verify current My Home Plus specifications with the specific retailer before purchase.

Headline specs for the Everflo: 14 kg weight, 350 W continuous power, 45 dB sound, 90–96% purity, OPI light, 7,500 ft altitude, 5.5 psi outlet, 1–5 LPM flow, full three-alarm suite (loss-of-power, system-malfunction, no-flow), FDA-approved, CE-certified, 3-year India warranty, Philips Respironics India service network. My Home Plus is typically positioned as a sub-₹35,000 budget 5 LPM concentrator with broadly similar flow rating (0.5–5 LPM) but without FDA or CE certification and without the Philips service depth.

HHZ’s verdict: the Philips Everflo wins this matchup decisively.

At-a-glance differences

• Price: My Home Plus typically below ₹35,000 vs Everflo ₹43,699 (since discontinued) — the saving depends on the specific My Home Plus SKU, typically ₹8,000–₹15,000
• Certification: Everflo is FDA-approved and CE-certified; My Home Plus is not documented as carrying either per publicly-available product listings
• Purity monitoring: Everflo has OPI light triggering below 82%; My Home Plus typically lacks OPI or analyzer
• Alarm suite: Everflo has three alarms (loss-of-power, system-malfunction, no-flow); My Home Plus typically runs one or no documented alarms
• Weight: Everflo 14 kg; My Home Plus typically 16–20 kg per class norm for Chinese-OEM budget 5 LPMs
• Power draw: Everflo 350 W; My Home Plus typically 350–400 W per class norm
• Service network: Philips Respironics India has authorised service in all major Indian metros and most Tier-2 cities; My Home Plus service is retailer-mediated

The Everflo is Indian-voltage, runs 220V / 50Hz, and ships with Indian retail documentation including CDSCO registration.

Where the Philips Everflo wins

FDA + CE certification. The Everflo is FDA-approved and CE-certified — the reference certification pair for imported respiratory equipment. Both certifications are the documentation floor for insurance reimbursement under CGHS, ECHS, ESIC, and private health-insurance schemes requiring durable medical equipment (DME) claims (CGHS). For any buyer who may later claim the purchase under insurance, the Everflo’s paperwork is comprehensive and accepted without friction.

Full alarm suite. Loss-of-power, system-malfunction, and no-flow alarms on the Everflo. These three alarms are the minimum safety infrastructure for a prescribed LTOT device. Loss-of-power alarms during mains outages force an immediate caregiver response. System-malfunction alarms catch compressor faults early. No-flow alarms catch disconnected or kinked cannulas. My Home Plus’ alarm profile is typically thinner, with loss-of-power alarms common but system-malfunction and no-flow alarms often missing from budget-tier imports.

Oxygen Purity Indicator. The Everflo’s OPI lights up if purity drops below 82%. For a multi-year LTOT prescription, this is the early-warning signal that sieve-beds need replacement. Without an OPI, the first sign of sieve degradation is patient desaturation — a clinical event rather than a warning.

Philips Respironics India service network. Philips operates dealer-authorised service in all major metros — Mumbai, Delhi, Bengaluru, Chennai, Kolkata, Hyderabad, Pune, Ahmedabad — with technicians trained on the Everflo platform and genuine replacement parts stocked locally. This is the deepest service network of any imported 5 LPM concentrator brand sold in India. For warranty claims, sieve-bed replacements (the single failure mode defining year-3 concentrator useful life), or compressor servicing, Philips’ India service depth is the benchmark.

Documented platform history. The Everflo has been in continuous production by Philips Respironics since 2008, with incremental platform refinements and well-documented failure modes. Clinical-engineer familiarity in Indian hospitals is high; the compressor platform is mature enough that servicing techniques are well-understood across multiple independent service providers.

Lightweight at 14 kg. The Everflo is among the lightest 5 LPMs sold in India — tied with the Airsep Visionaire (13.6 kg) and the Oxymed Mini (13.9 kg) at the top of the weight rankings. Budget imports in the sub-₹35,000 segment typically run 16–20 kg chassis weights, making the Everflo easier to move between rooms.

3-year manufacturer warranty backed by Philips India. Philips Respironics India handles warranty claims through authorised dealers with documented service-level agreements. The warranty experience is generally reported as consistent across claims.

Where My Home Plus wins

Lower upfront cost. The central My Home Plus advantage is the purchase price. Budget 5 LPM imports in the sub-₹35,000 band undercut the Everflo by ₹8,000–₹15,000 depending on the specific SKU and channel. For a cash-constrained buyer with a short-duration prescription (30–90 days post-COVID recovery, short-term bridging therapy, secondary backup unit), the lower upfront cost is a real advantage.

Potentially lower power draw. Some budget 5 LPM imports document power draws in the 285–320 W range, below the Everflo’s 350 W. Over a 3-year 24-hour prescription, a 50 W gap translates to roughly ₹125 per month or ₹4,500 over the full period — a saving that partially offsets the Everflo’s certification premium. This advantage, however, depends on the specific My Home Plus SKU and its actual power draw.

Beyond price and potentially lower power draw, the My Home Plus category does not typically offer features that the Everflo lacks. FDA approval, CE certification, Philips-grade service network, and platform maturity are all on the Everflo’s side.

Indian-market context

The Indian 5 LPM stationary market is bifurcated between FDA-approved imported units (Philips Everflo, Drive DeVilbiss, Airsep Visionaire, Nidek Nuvo) in the ₹43,000–₹55,000 band and budget Chinese-OEM imports (Veayva, Vandelay, S.Cure, Dynmed, and branded units like My Home Plus) in the ₹27,000–₹40,000 band. The bifurcation is driven by certification: the former group has FDA or FDA+CE, the latter typically does not.

For insurance reimbursement, hospital-channel procurement, and formal CDSCO documentation, the FDA-approved group is routinely accepted. The budget-import group faces inconsistent certification paperwork and reimbursement pushback. For a cash purchase with no reimbursement expectation, either group can serve; for a buyer who may later claim the expense, the FDA-approved group is the safer purchase.

Service-network depth differs sharply. Philips Respironics India has invested in dealer-authorised service infrastructure across two decades; budget-import brands typically rely on retailer-mediated warranty routes that weaken when retailers rotate stock or de-list products. For a 3-year prescription window, the Philips service depth is the more defensible choice.

GST applies at 12% on both. Both require a 1.5–2 kVA servo stabiliser in Indian regions with sub-180V mains variance (common in Tier-2 and Tier-3 cities). Altitude handling: the Everflo rates 7,500 ft, which covers Shimla, Manali, Mussoorie, Gangtok, Darjeeling, Ooty, and Munnar without derating. My Home Plus altitude envelope varies by SKU and is often not published.

Indian Railways oxygen-carriage policies permit 5 LPM stationary concentrators on long-distance travel in AC and sleeper classes with advance permission from the railway medical authority. Both units would be eligible subject to prior permission.

Verdict — who should pick which

Pick the Philips Everflo 5 LPM if: you want FDA-approved, CE-certified, Philips Respironics India-supported hardware with a full alarm suite, OPI, and a 3-year warranty; you may claim the purchase under insurance reimbursement; you live in an Indian city where Philips authorised-service is available (all major metros and most Tier-2 cities); you prioritise service-network depth over upfront cost. This covers virtually every Indian home-prescription buyer planning a multi-year LTOT course in the mid-to-premium price segment. The Everflo is the reference 5 LPM imported unit for India in 2026 and the obvious pick when the budget allows.

Pick My Home Plus or a similar budget import if: upfront cost is a binding constraint, the prescription is short (under 90 days), the buyer does not intend to claim insurance reimbursement, the household has a secondary oxygen backup (cylinder or second concentrator), and the ₹8,000–₹15,000 saving is worth more than the lost certification and service depth. This is a narrow use case.

Consider alternatives if: the buyer’s budget sits between My Home Plus and the Everflo. The Oxymed Mini at ₹35,400 is an Indian-manufactured 5 LPM with a live percent purity analyzer, full three-alarm suite, CDSCO registration, 3-year warranty, and India’s largest domestic-brand authorised-service network (40+ cities). At ₹8,299 less than the Everflo, the Oxymed Mini is the defensible middle-ground pick — better-specified than most budget imports, and materially cheaper than the Everflo while clearing the Indian regulatory and safety-alarm floor. The BPL Oxy 5 Neo at ₹31,966 is another sub-Everflo option, though heavier (25 kg) and louder (55 dB).

HHZ’s firm pick in this matchup is the Philips Everflo 5 LPM. FDA approval, CE certification, full alarms, OPI, 14 kg chassis, Philips India service depth, and a 3-year warranty add up to the most complete package in the sub-₹50,000 imported class. For buyers who can stretch to ₹43,699 (since discontinued), the Everflo is the reference 5 LPM for Indian home LTOT in 2026. For buyers below that budget, the Oxymed Mini at ₹35,400 is the HHZ-recommended step-down rather than My Home Plus. Consult your treating pulmonologist before finalising the flow-rate prescription — the 5 LPM class buys headroom, but the titration is the clinical decision that matters most.